Armstrong, G. D., Mulvey, G. L., Marcato, P., Griener, T. P., Kahan, M. C., Tennent, G. A., Sabin, C. A., Chart, H., & Pepys, M. B. (2006). Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome. Journal of Infectious Diseases, 193(8), 1120-1124. https://doi.org/10.1086/501472
Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome. / Armstrong, Glen D.; Mulvey, George L.
; Marcato, Paola 等.
在:
Journal of Infectious Diseases, 卷 193, 号码 8, 15.04.2006, 页码 1120-1124.
科研成果: 期刊稿件 › 文章 › 同行评审
Armstrong, GD, Mulvey, GL, Marcato, P, Griener, TP, Kahan, MC, Tennent, GA, Sabin, CA, Chart, H & Pepys, MB 2006, 'Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome', Journal of Infectious Diseases, 卷 193, 号码 8, 页码 1120-1124. https://doi.org/10.1086/501472
Armstrong GD, Mulvey GL, Marcato P, Griener TP, Kahan MC, Tennent GA 等. Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome. Journal of Infectious Diseases. 2006 4月 15;193(8):1120-1124. doi: 10.1086/501472
Armstrong, Glen D. ; Mulvey, George L. ; Marcato, Paola 等. / Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo : Therapeutic implications for hemolytic-uremic syndrome. 在: Journal of Infectious Diseases. 2006 ; 卷 193, 号码 8. 页码 1120-1124.
@article{e58a78b7a06d4e54855d84c00eca7f82,
title = "Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome",
author = "Armstrong, {Glen D.} and Mulvey, {George L.} and Paola Marcato and Griener, {Thomas P.} and Kahan, {Melvyn C.} and Tennent, {Glenys A.} and Sabin, {Caroline A.} and Henrik Chart and Pepys, {Mark B.}",
note = "Funding Information: Financial support: Canadian Institutes for Health Research (operating grant MWS 56081 to G.D.A. and doctoral scholarship to P.M.); Canadian Bacterial Diseases Network (operating grant VP 17 to G.D.A.); Alberta Heritage Foundation for Medical Research (doctoral scholarship to P.M.); UK Medical Research Council Programme (grant G97900510 to M.B.P.).",
year = "2006",
month = apr,
day = "15",
doi = "10.1086/501472",
language = "English",
volume = "193",
pages = "1120--1124",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "8",
}
TY - JOUR
T1 - Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo
T2 - Therapeutic implications for hemolytic-uremic syndrome
AU - Armstrong, Glen D.
AU - Mulvey, George L.
AU - Marcato, Paola
AU - Griener, Thomas P.
AU - Kahan, Melvyn C.
AU - Tennent, Glenys A.
AU - Sabin, Caroline A.
AU - Chart, Henrik
AU - Pepys, Mark B.
N1 - Funding Information:
Financial support: Canadian Institutes for Health Research (operating grant MWS 56081 to G.D.A. and doctoral scholarship to P.M.); Canadian Bacterial Diseases Network (operating grant VP 17 to G.D.A.); Alberta Heritage Foundation for Medical Research (doctoral scholarship to P.M.); UK Medical Research Council Programme (grant G97900510 to M.B.P.).
PY - 2006/4/15
Y1 - 2006/4/15
UR - http://www.scopus.com/inward/record.url?scp=33645762261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645762261&partnerID=8YFLogxK
U2 - 10.1086/501472
DO - 10.1086/501472
M3 - Article
C2 - 16544252
AN - SCOPUS:33645762261
SN - 0022-1899
VL - 193
SP - 1120
EP - 1124
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 8
ER -